7[1]O'Brian CA, Ward NE, Stewart JR, et al. Prospects for targeting protein kinase C isozymes in the therapy of drug-resistant cancerAn evolving story [J]. Cancer Metastasis Rev, 2001;20(1-2):95-100.
8[3]Van Gijn R, van Tellingen O, Haverkate E, et al. Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in mice[J]. Invest New Drugs, 1999; 17(1): 29-41.
9[4]Hofmann J. Modulation of protein kinase C in antitumor treatment [J]. Rev Physiol Biochem Pharmacol, 2001;142:1-196.
10[5]Fabbro D, Ruetz S, Bodis S, et al. PKC412a protein kinase inhibitor with a broad therapeutic potential[J]. Anticancer Drug Des, 2000;15(1):17-28.
